Refine Search
(24)
(55)
(81)
(190)

Infectious Disease

GlobalData provides unique and market-leading data and insights into the infectious disease market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Seasonal Influenza: Competitive Landscape to 2026

  • $3,495
  • November 2018
Add to Basket Quick View Add to Saved List

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The influenza A H1N1 and H3N2, and influenza B strains are those responsible for season...

Malaria: Epidemiology Forecast to 2027

  • $3,995
  • November 2018
Add to Basket Quick View Add to Saved List

Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the female Anopheles mosquito. Upon infecting a new human host, parasites first travel to liver cells and eventually infec...

Malaria: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • November 2018
Add to Basket Quick View Add to Saved List

Malaria is a potentially life-threatening disease caused by Plasmodium parasites, which are transmitted to humans through the bites of infected female Anopheles spp mosquitoes. For over 2,500 years, fevers, a hallmark symptom of malaria, were a...

Digital Landscape: HIV

  • $6,000
  • October 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape HIV report analyzes digital activities undertaken by pharma in support of therapies for the treatment of HIV

Competitor Landscape: HIV

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the HIV market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Pha...

KOL Perspectives: Perceptions of recent & upcoming data for key HBV pipeline agents

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

This KOL Insight briefing focuses on KOLs views of recent & upcoming data for key HBV pipeline agents

Pertussis (Whooping Cough) Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Pertussis (Whooping Cough) Global Clinical Trials Review, H2, 2018" provides an overview of Pertussis (Whooping Cough) clinical trials scenario. This report provides top line data relating to the cl...

Abdominal Abscess Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Abdominal Abscess Global Clinical Trials Review, H2, 2018" provides an overview of Abdominal Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on A...

Yellow Fever Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2018" provides an overview of Yellow Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Yellow Feve...

Zika Virus Infections Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Zika Virus Infections Global Clinical Trials Review, H2, 2018" provides an overview of Zika Virus Infections clinical trials scenario. This report provides top line data relating to the clinical tri...

Abscess Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H2, 2018" provides an overview of Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abscess. Report inclu...

Adenoviridae Infections Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Adenoviridae Infections Global Clinical Trials Review, H2, 2018" provides an overview of Adenoviridae Infections clinical trials scenario. This report provides top line data relating to the clinical...

African Trypanosomiasis Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “African Trypanosomiasis Global Clinical Trials Review, H2, 2018" provides an overview of African Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical...

Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H2, 2018" provides an overview of Ancylostomiasis (Hookworm Infections) clinical trials scenario. This report provides top line d...

Anthrax Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2018" provides an overview of Anthrax clinical trials scenario. This report provides top line data relating to the clinical trials on Anthrax. Report inclu...